News - Research & development
MMV creates the Open Source Drug Discovery Programme
The Bill and Melinda Gates Foundation is seeking proposals for new approaches for the interrogation of antimalarial compounds
Prof. Kelly Chibale has received two awards for his outstanding contributions to scientific research in South Africa for South Africans
Pioneering MMV research published in PLoS Medicine compares the activity of antimalarial medicines at every step of the parasite’s lifecycle
This new antimalarial is indicated for P. falciparum and blood stage P. vivax malaria
If so, we want to hear about it and could offer you an MMV Challenge Grant to turn that idea into reality
Prof. Brian Greenwood is bestowed the title ‘Knights Bachelor’ by HRH Queen Elizabeth for his services to malaria research in Africa
Carefully selected by experienced chemists these free compounds are set to propel malaria drug discovery to the next level
This fixed-dose combination of dihydroartemisinin and piperaquine is administered once a day for 3 days
Novartis and MMV have identified a new class of compounds that targets both the blood- and liver-stage infections of malaria
